RU Pawankar, M Okuda, S Hasegawa, K Suzuki, H Yssel, K Okubo, K Okumura and C Ra
Department of Otolaryngology, Nippon Medical School, Tokyo, Japan.

Allergic rhinitis is an IgE mediated atopic disease characterized by elevated levels of allergen specific IgE antibodies that play a central role in mediating allergic reactions. Interleukin 13 (IL-13) is a novel T-cell-derived cytokine that shares several functional properties with IL-4 and has been demonstrated to be capable of inducing IgE synthesis. The present study was designed to investigate the expression of IL-13 gene in the epithelial compartment of the nasal mucosa of patients with perennial allergic rhinitis (PAR) to house dust mite, comparing it with that in the nasal epithelial compartment of chronic infectious rhinitis (CIR) patients and normal volunteers (NV). We also investigated the IL- 13 gene expression in the peripheral blood of PAR patients. Nasal scrapings were collected from the inferior turbinate of patients undergoing conchotomy surgery and from outpatients, and the mRNA expression of IL-13 was analyzed by the RT-PCR method. Peripheral blood mononuclear cells were isolated by density-gradient centrifugation and the expression of IL-13 gene was examined by the RT-PCR method. IL-13 expression at protein level and its cell source were analyzed by immunohistochemistry of inferior turbinate biopsies. The levels of total serum IgE and allergen-specific IgE antibodies in the serum were estimated by the PRIST and CAP RAST method, respectively. IL-13 gene expression was detected in the epithelial compartment of the nasal mucosa of 18/19 PAR patients but was undetected in normal volunteers and CIR patients.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S. M. Pope, P. C. Fulkerson, C. Blanchard, H. S. Akei, N. M. Nikolaidis, N. Zimmermann, J. D. Molkentin, and M. E. Rothenberg Identification of a Cooperative Mechanism Involving Interleukin-13 and Eotaxin-2 in Experimental Allergic Lung Inflammation J. Biol. Chem., April 8, 2005; 280(14): 13952 - 13961. [Abstract] [Full Text] [PDF]

				Q. Peng, T. Matsuda, and S. J. Hirst Signaling Pathways Regulating Interleukin-13-stimulated Chemokine Release from Airway Smooth Muscle Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 596 - 603. [Abstract] [Full Text] [PDF]

				H Milgrom Is there a role for treatment of asthma with omalizumab? Arch. Dis. Child., January 1, 2003; 88(1): 71 - 74. [Abstract] [Full Text] [PDF]

				J. G. VAN DEN BERG, J. ATEN, M. A. CHAND, N. CLAESSEN, L. DIJKINK, J. WIJDENES, F. G. LAKKIS, and J. J. WEENING Interleukin-4 and Interleukin- 13 Act on Glomerular Visceral Epithelial Cells J. Am. Soc. Nephrol., March 1, 2000; 11(3): 413 - 422. [Abstract] [Full Text] [PDF]

				Y. Li, F. E. R. Simons, and K. T. HayGlass Environmental Antigen-Induced IL-13 Responses Are Elevated Among Subjects with Allergic Rhinitis, Are Independent of IL-4, and Are Inhibited by Endogenous IFN-{gamma} Synthesis J. Immunol., December 15, 1998; 161(12): 7007 - 7014. [Abstract] [Full Text] [PDF]

				O. Ghaffar, S. Laberge, M. R. Jacobson, O. Lowhagen, S. Rak, S. R. Durham, and Q. Hamid IL-13 mRNA and Immunoreactivity in Allergen-induced Rhinitis: Comparison with IL-4 Expression and Modulation by Topical Glucocorticoid Therapy Am. J. Respir. Cell Mol. Biol., July 1, 1997; 17(1): 17 - 24. [Abstract] [Full Text]

				Y. Oshima and R. K. Puri Characterization of a Powerful High Affinity Antagonist That Inhibits Biological Activities of Human Interleukin-13 J. Biol. Chem., April 27, 2001; 276(18): 15185 - 15191. [Abstract] [Full Text] [PDF]

				H. Danahay, H. Atherton, G. Jones, R. J. Bridges, and C. T. Poll Interleukin-13 induces a hypersecretory ion transport phenotype in human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, February 1, 2002; 282(2): L226 - L236. [Abstract] [Full Text] [PDF]